ARCHIVES

Saul Rivin Receives ACCC Clinical Research Award.

This article is from The Cancer Letter archive.

Vol. 26 No. 44 | December 1, 2000

Download PDF Visit The Full Archive

Related Articles

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

January 7, 2005

NCI And SPORE PIs Discussing Potential Changes To Grant Program Guidelines.

September 19, 2008

President Accepts Rauscher Resignation

October 1, 1976

Lasker Awards Resume; ASCO Fall Conference Scheduled For October

September 21, 1990

US Oncology Begins Trial Of Taxotere And Xeloda

September 27, 2002

Therapeutic Modalities Improve Patient Quality of Life In Trials

February 27, 2004